Inrad Optics, Inc. - Quarter Report: 2009 September (Form 10-Q)
UNITED
STATES
SECURITIES
AND EXCHANGE COMMISSION
Washington,
D.C. 20549
FORM
10-Q
(Mark
One)
x
|
QUARTERLY
REPORT PURSUANT TO SECTION 13 OR 15(d) OF
THE SECURITIES EXCHANGE ACT OF 1934
|
For the
quarterly period ended SEPTEMBER 30,
2009
OR
o
|
TRANSITION
REPORT PURSUANT TO SECTION 13 OR 15(d) OF
THE SECURITIES EXCHANGE ACT OF 1934
|
For the
transition period
from _____________ to _______________
Commission
file number 0-11668
PHOTONIC PRODUCTS GROUP,
INC.
(Exact
name of registrant as specified in its charter)
New
Jersey
|
22-2003247
|
(State
or other jurisdiction of incorporation
|
(I.R.S.
Employer
|
Identification
Number)
|
or
organization)
|
181 Legrand Avenue,
Northvale, NJ 07647
(Address
of principal executive offices)
(Zip
Code)
(201)
767-1910
(Registrant’s
telephone number, including area code)
_____________________________________________________________
(Former
name, former address and formal fiscal year, if changed since last
report)
Indicate by check mark whether the
registrant (1) has filed all reports required to be filed by Section 13 or 15(d)
of the Securities Exchange Act of 1934 during the preceding 12 months (or for
such shorter period that the registrant was required to file such reports), and
(2) has been subject to such filing requirements for the past 90
days.
Yes x No o
Indicate
by check mark whether the registrant has submitted electronically and posted on
its corporate Web site, if any, every Interactive Data file required to be
submitted and posted pursuant to Rule 405 of Regulation S-T
(§ 232.405 of this chapter) during the preceding 12 months (or for
such shorter period that the registrant was required to submit and post such
files). Yes o
No o The Registrant is
not yet subject to this requirement.
Indicate
by check mark whether the registrant is a large accelerated filer, an
accelerated filer, a non-accelerated filer or a smaller reporting
company. See definition of “large accelerated filer, accelerated
filer and smaller reporting company” in Rule 12b-2 of the exchange
Act. (Check one):
Large
accelerated filer o
|
Accelerated
filer o
|
Non-accelerated
filer o
|
Smaller
reporting company x
|
Indicate
by check mark whether the registrant is a shell company (as defined in Rule
12b-2 of the Exchange act).
Yes o No x
Common
shares of stock outstanding as of November 16, 2009:
11,420,384
shares
Photonic
Products Group, Inc. and Subsidiaries
INDEX
Part
I. CONDENSED FINANCIAL INFORMATION
|
||
Item
1. Financial Statements:
|
||
Condensed
consolidated balance sheets as of September 30, 2009 (unaudited) and
December 31, 2008 (audited)
|
1
|
|
Condensed
consolidated statements of operations for the three and nine
months ended September 30, 2009 and 2008
(unaudited)
|
2
|
|
|
||
Condensed
consolidated statements of cash flows for the nine months
ended September 30, 2009 and 2008 (unaudited)
|
3
|
|
|
||
Notes
to condensed consolidated financial statements (unaudited)
|
4
|
|
|
||
Item
2. Management's Discussion and Analysis of Financial Condition and Results
of Operations
|
13
|
|
|
||
Item
3. Quantitative and Qualitative Disclosures about Market
Risk
|
19
|
|
|
||
Item
4. Controls and Procedures
|
19
|
|
|
||
Part
II. OTHER
INFORMATION
|
|
|
|
||
Item
1. Legal
Proceedings
|
20
|
|
|
||
Item
1A. Risk
Factors
|
20
|
|
|
||
Item
2. Unregistered
Sales of Equity Securities and Use of Proceeds
|
20
|
|
|
||
Item
3. Defaults
upon Senior Securities
|
20
|
|
|
||
Item
4. Submission
of Matters to a Vote of Security Holders
|
20
|
|
|
||
Item
5. Other
Information
|
20
|
|
|
||
Item
6. Exhibits
|
20
|
|
|
||
Signatures
|
21
|
CONDENSED
CONSOLIDATED BALANCE SHEETS
September 30,
|
December 31,
|
|||||||
2009
|
2008
|
|||||||
(Unaudited)
|
(Audited)
|
|||||||
Assets
|
||||||||
Current
assets:
|
||||||||
Cash
and cash equivalents
|
$ | 3,753,759 | $ | 2,672,087 | ||||
Certificates
of deposit
|
— | 800,000 | ||||||
Accounts
receivable (net of allowance for doubtful accounts of $15,000
in 2009 and 2008)
|
1,716,993 | 2,810,602 | ||||||
Inventories,
net
|
2,440,196 | 2,732,336 | ||||||
Other
current assets
|
186,778 | 188,084 | ||||||
Total
current assets
|
8,097,726 | 9,203,109 | ||||||
Plant
and equipment:
|
||||||||
Plant
and equipment, at cost
|
14,584,207 | 14,445,027 | ||||||
Less:
Accumulated depreciation and amortization
|
(11,834,559 | ) | (11,139,771 | ) | ||||
Total
plant and equipment
|
2,749,648 | 3,305,256 | ||||||
Precious
Metals
|
157,443 | 112,851 | ||||||
Deferred
Income Taxes
|
408,000 | 408,000 | ||||||
Goodwill
|
311,572 | 1,869,646 | ||||||
Intangible
Assets, net
|
692,657 | 751,580 | ||||||
Other
Assets
|
47,601 | 81,707 | ||||||
Total
Assets
|
$ | 12,464,647 | $ | 15,732,149 | ||||
Liabilities and
Shareholders’ Equity
|
||||||||
Current
Liabilities:
|
||||||||
Current
portion of other long term notes
|
$ | 9,000 | $ | 136,892 | ||||
Accounts
payable and accrued liabilities
|
1,735,910 | 2,160,665 | ||||||
Customer
advances
|
115,667 | 456,754 | ||||||
Total
current liabilities
|
1,860,577 | 2,754,311 | ||||||
Related
Party Convertible Notes Payable
|
2,500,000 | 2,500,000 | ||||||
Other
Long Term Notes, net of current portion
|
347,167 | 353,663 | ||||||
Total
liabilities
|
4,707,744 | 5,607,974 | ||||||
Commitments
and Contingencies
|
— | — | ||||||
Shareholders’
Equity:
|
||||||||
Common
stock: $.01 par value; 60,000,000 authorized shares; 11,414,984 shares
issued at September 30, 2009 and 11,230,678 issued
at December 31, 2008
|
114,149 | 112,306 | ||||||
Capital
in excess of par value
|
17,027,088 | 16,622,466 | ||||||
Accumulated
deficit
|
(9,369,384 | ) | (6,595,647 | ) | ||||
7,325,224 | 10,139,125 | |||||||
Less
- Common stock in treasury, at cost (4,600 shares
respectively)
|
(14,950 | ) | (14,950 | ) | ||||
Total
Shareholders’ Equity
|
7,771,853 | 10,124,175 | ||||||
Total
Liabilities and Shareholders’ Equity
|
$ | 12,464,647 | $ | 15,732,149 |
See Notes
to Condensed Consolidated Financial Statements (Unaudited)
1
CONDENSED
CONSOLIDATED STATEMENTS OF OPERATIONS
(Unaudited)
Three Months Ended September 30,
|
Nine Months Ended September
30,
|
|||||||||||||||
2009
|
2008
|
2009
|
2008
|
|||||||||||||
Total
revenue
|
$ | 2,664,963 | 3,802,935 | $ | 8,100,497 | $ | 11,974,595 | |||||||||
Cost
and expenses:
|
||||||||||||||||
Cost
of goods sold
|
2,058,433 | 2,737,511 | 6,693,182 | 8,188,376 | ||||||||||||
Selling,
general and administrative expenses
|
746,511 | 949,125 | 2,533,442 | 2,913,853 | ||||||||||||
Goodwill
impairment charge
|
1,558,074 | — | 1,558,074 | — | ||||||||||||
4,363,018 | 3,686,636 | 10,784,698 | 11,102,229 | |||||||||||||
(Loss)
income from operations
|
(1,698,055 | ) | 116,299 | (2,684,201 | ) | 872,366 | ||||||||||
Other
expense:
|
||||||||||||||||
Interest
expense—net
|
(32,275 | ) | (33,179 | ) | (96,907 | ) | (143,142 | ) | ||||||||
Gain
on sale of precious metals
|
— | — | 7,371 | — | ||||||||||||
Gain
on sale of fixed assets
|
— | — | — | 9,113 | ||||||||||||
(32,275 | ) | (33,179 | ) | (89,536 | ) | (134,029 | ) | |||||||||
Net
(loss) income before income taxes
|
(1,730,330 | ) | 83,120 | (2,773,737 | ) | 738,337 | ||||||||||
Deferred
tax provision (benefit)
|
392,000 | (86,000 | ) | — | (216,000 | ) | ||||||||||
Net
(loss) income
|
$ | (2,122,330 | ) | $ | 169,120 | $ | (2,773,737 | ) | $ | 954,337 | ||||||
Net
(loss) income per common share— basic
|
$ | (0.19 | ) | $ | 0.02 | $ | (0.25 | ) | $ | 0.09 | ||||||
Net
(loss) income per common share— diluted
|
$ | (0.19 | ) | $ | 0.01 | $ | (0.25 | ) | $ | 0.07 | ||||||
Weighted
average shares outstanding—basic
|
11,404,247 | 11,209,576 | 11,311,574 | 10,824,457 | ||||||||||||
Weighted
average shares outstanding—diluted
|
11,404,247 | 15,461,922 | 11,311,574 | 15,691,982 |
See Notes
to Condensed Consolidated Financial Statements (Unaudited)
2
CONDENSED
CONSOLIDATED STATEMENTS OF CASH FLOWS
(Unaudited)
Nine
Months Ended September 30,
|
||||||||
2009
|
2008
|
|||||||
Cash
flows from operating activities:
|
||||||||
Net
(loss) income
|
$ | (2,773,737 | ) | $ | 954,337 | |||
Adjustments
to reconcile net (loss) income to cash provided by operating
activities:
|
||||||||
Depreciation
and amortization
|
753,711 | 802,088 | ||||||
Common
stock contribution to retirement plan
|
179,068 | 160,181 | ||||||
Goodwill
impairment charge
|
1,558,074 | — | ||||||
Gain
on sale of fixed assets
|
— | (9,113 | ) | |||||
Gain
on sale of precious metals
|
(7,371 | ) | — | |||||
Deferred
income taxes
|
— | (306,000 | ) | |||||
Stock
based compensation
|
86,433 | 56,569 | ||||||
Changes
in operating assets and liabilities:
|
||||||||
Accounts
receivable
|
1,093,609 | 232,617 | ||||||
Inventories,
net
|
292,140 | (295,668 | ) | |||||
Other
current assets
|
1,306 | (44,686 | ) | |||||
Other
assets
|
34,106 | 38,221 | ||||||
Accounts
payable and accrued liabilities
|
(424,755 | ) | (721,355 | ) | ||||
Customer
advances
|
(341,087 | ) | 11,674 | |||||
Total
adjustments and changes
|
3,225,234 | (75,472 | ) | |||||
Net
cash provided by operating activities
|
451,497 | 878,865 | ||||||
Cash flows from investing
activities:
|
||||||||
Capital
expenditures
|
(139,180 | ) | (726,127 | ) | ||||
Purchase
of precious metals
|
(53,538 | ) | — | |||||
Proceeds
from redemption of certificates of deposit
|
800,000 | — | ||||||
Proceeds
from sale of fixed assets
|
— | 10,000 | ||||||
Proceeds
from sale of precious metals
|
16,317 | — | ||||||
Net
cash provided by (used in) investing activities
|
623,599 | (716,127 | ) | |||||
Cash
flows from financing activities:
|
||||||||
Redemption
of restricted stock units
|
(1,861 | ) | — | |||||
Proceeds
from exercise of stock options
|
75,325 | 258,255 | ||||||
Proceeds
from exercise of warrants
|
67,500 | 807,587 | ||||||
Principal
payment of convertible note payable
|
— | (1,700,000 | ) | |||||
Principal
payments of other notes payable
|
(134,388 | ) | (11,155 | ) | ||||
Principal
payments of capital lease obligations
|
— | (47,088 | ) | |||||
Net
cash provided by (used in) financing activities
|
6,576 | (692,401 | ) | |||||
Net
increase (decrease) in cash and cash equivalents
|
1,081,672 | (529,663 | ) | |||||
Cash
and cash equivalents at beginning of period
|
2,672,087 | 4,395,945 | ||||||
Cash
and cash equivalents at end of period
|
$ | 3,753,759 | $ | 3,866,282 |
Supplemental
Disclosure of Cash Flow Information:
|
||||||||||
Interest
paid
|
$ | 15,056 | $ | 488,550 | ||||||
Income
taxes paid
|
$ | 25,000 | $ | 360,000 |
See Notes
to Condensed Consolidated Financial Statements (Unaudited)
3
PHOTONIC
PRODUCTS GROUP, INC AND SUBSIDIARIES
NOTES
TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
(Unaudited)
NOTE
1 -SUMMARY OF
SIGNIFICANT ACCOUNTING POLICIES
Basis
of Presentation
The
accompanying unaudited condensed consolidated financial statements include the
accounts of Photonic Products Group, Inc. and its subsidiaries (collectively,
the “Company”). All significant intercompany balances and transactions
have been eliminated.
The
consolidated financial statements have been prepared in accordance with U.S.
generally accepted accounting principles (“U.S. GAAP”) for interim financial
information and with the instructions to Form 10-Q and Rule 10-01 of
Regulation S-X. Accordingly, they do not include all of the information
and footnotes required by U.S. GAAP for complete financial statements. In
the opinion of management, all adjustments of a normal recurring nature
considered necessary for a fair presentation have been included. The
results of operations of any interim period are not necessarily indicative of
the results of operations to be expected for the full fiscal year. For
further information, refer to the consolidated financial statements and
accompanying footnotes included in the Company’s Annual Report on Form 10-K
for the year ended December 31, 2008.
In
preparing these consolidated financial statements, the Company has evaluated
events and transactions for potential recognition or disclosure through November
16, 2009, the date the consolidated financial statements were
issued.
Management
Estimates
These
unaudited financial statements and related disclosures have been prepared in
conformity with U.S. GAAP which requires management to make estimates and
assumptions that affect the reported amounts of assets and liabilities and
disclosure of contingent assets and liabilities at the date of the financial
statements and the reported amounts of revenues and expenses reported in those
financial statements. Management evaluates its estimates and
assumptions on an ongoing basis using historical experience and other factors,
including the current economic environment, and makes adjustments when facts and
circumstances dictate. As future events and their effects cannot be
determined with precision, actual results could differ significantly from those
estimates and assumptions. Significant changes, if any, in those estimates
resulting from continuing changes in the economic environment will be reflected
in the consolidated financial statements in future periods.
Inventories
Inventories
are stated at the lower of cost (first-in-first-out basis) or
market. Cost of manufactured goods includes material, labor and
overhead. The Company records a reserve for slow moving inventory as
a charge against earnings for all products identified as surplus, slow-moving or
discontinued. Excess work-in-process costs are charged against
earnings whenever estimated costs-of-completion exceed unbilled
revenues.
4
Inventories
are comprised of the following and are shown net of inventory
reserves:
September
30,
2009
|
December
31, 2008
|
|||||||
(Unaudited)
|
||||||||
(in
thousands)
|
||||||||
Raw materials
|
$ | 1,125 | $ | 1,169 | ||||
Work
in process, including manufactured parts and components
|
730 | 1,117 | ||||||
Finished
goods
|
585 | 446 | ||||||
$ | 2,440 | $ | 2,732 |
Income
Taxes
The
Company uses the asset and liability method of accounting for income
tax. This method recognizes deferred tax liabilities and assets for
the expected future tax consequences of events that have been recognized in the
Company’s financial statements or tax returns. Deferred tax
liabilities and assets are determined based on the difference between the
financial statements carrying amounts and the tax basis of assets and
liabilities using enacted tax rates in effect in the years in which the
differences are expected to reverse. Valuation allowances are provided against
deferred tax assets, including net operating losses, if it is anticipated that
it is more likely than not that they will not be realized through future taxable
earnings or implementation of tax planning strategies.
The
Company recorded a tax benefit of $392,000 related to the recognition of
deferred tax assets for net operating losses incurred during the first six
months of 2009. In the third quarter, due to the negative impact of
the economic recession on the Company’s profitability, we reevaluated the
likelihood that the benefit of deferred tax assets would be realized in future
periods. As a result, we increased our estimate of the valuation
allowance, in the third quarter, to a level that, in management’s judgment,
would meet the more likely than not threshold, and we recorded a valuation
allowance against our deferred tax assets and a corresponding deferred tax
provision in the amount of $392,000. This offset the benefit recorded in the
first six months of the year.
In
evaluating the Company’s ability to recover deferred tax assets in future
periods, management considered the available positive and negative factors,
including the Company’s past operating results, the existence of cumulative
losses and near term forecasts of future taxable income that is consistent with
the plans and estimates management is using to manage the underlying business
and concluded that it was more likely than not that the tax benefits would not
be fully recoverable in future periods. As of September 30, 2009, the
Company has recognized $408,000 of its deferred tax asset, net of a valuation
allowance of $2,441,000 which it estimates will be recoverable in future
periods.
The
Company recognizes a tax benefit from an uncertain tax position only if it is
more likely than not to be sustained before being recognized in the financial
statements. The tax benefits recognized in the financial statements
from such positions are measured based on the largest benefit that has a more
likely than not chance of being realized upon ultimate
resolution. The Company recognizes potential interest and penalties
related to income tax positions as a component of the provision for income taxes
on the consolidated statements of income in any futures periods in which the
Company must record a liability. Since the Company has not recorded a liability
related to uncertain tax positions at September 30, 2009, there was no
impact on the Company’s effective tax rate.
5
Net
(Loss) Income per Common Share
The
Company computes and presents net (loss) income per common share in accordance
with FASB ASC Topic 260, “Earnings Per Share”. Basic (loss) income per common
share is computed by dividing net (loss) income by the weighted average number
of common shares outstanding. Diluted (loss) income per common share is computed
by dividing net (loss) income by the weighted average number of common shares
and common stock equivalents outstanding, calculated on the treasury stock
method for options, stock grants and warrants using the average market prices
during the period, including potential common shares issuable upon conversion of
outstanding convertible notes. For the three and nine months ended September 30,
2009, the potential dilutive effect of all common equivalent shares outstanding
have been excluded from the diluted computation because their effect is
anti-dilutive. The weighted average number of outstanding
anti-dilutive common stock options and grants, excluded from the computation of
diluted net income per common share for the three months and nine months ended
September 30, 2009 were 194,000 and 231,000, respectively. The weighted
average number of outstanding anti-dilutive warrants excluded from the
computation of diluted net income per common share for the three months and nine
months ended September 30, 2008 were 14,000 and 282,000, respectively. The
weighted average number of anti-dilutive common shares issuable upon conversion
of outstanding convertible notes for the three months and nine months ended
September 30, 2009 was 2,500,000. A reconciliation of the shares used in
the calculation of basic and diluted earnings per common share is as
follows:
Three Months Ended September
30, 2009 |
Three Months Ended
September 30, 2008
|
|||||||||||||||||||||||
Income(Loss)
|
Shares
|
Per Share
|
Income(Loss)
|
Shares
|
Per Share
|
|||||||||||||||||||
(Numerator)
|
(Denominator)
|
Amount
|
(Numerator)
|
(Denominator)
|
Amount
|
|||||||||||||||||||
Basic (Loss) Income Per
Share:
|
||||||||||||||||||||||||
Net
(Loss) Income
|
$ | (2,122,330 | ) | 11,404,257 | $ | (0.19 | ) ) | $ | 169,120 | 11,209,576 | $ | 0.02 | ||||||||||||
Effect
of dilutive securities:
|
||||||||||||||||||||||||
Convertible
Debt
|
— | — | 37,500 | 2,500,000 | ||||||||||||||||||||
Warrants
|
— | — | — | 1,311,477 | ||||||||||||||||||||
Options
and stock grants
|
— | — | — | 440,869 | ||||||||||||||||||||
Diluted
(Loss) Income Per Share:
|
||||||||||||||||||||||||
Net
(Loss) Income Applicable to Common Shareholders
|
$ | (2,122,230 | ) | 11,404,257 | $ | (0.19 | ) | $ | 206,620 | 15,461,922 | $ | 0.01 |
Nine Months Ended
September 30, 2009
|
Nine Months Ended
September 30, 2008
|
|||||||||||||||||||||||
Income(Loss)
(Numerator)
|
Shares
(Denominator)
|
Per Share
Amount
|
Income(Loss)
(Numerator)
|
Shares
(Denominator)
|
Per Share
Amount
|
|||||||||||||||||||
Basic
(Loss) Income Per Share:
|
||||||||||||||||||||||||
Net
(Loss) Income
|
$ | (2,773,737 | ) | 11,311,574 | $ | (0.25 | ) | $ | 954,337 | 10,824,457 | $ | 0.09 | ||||||||||||
Effect
of dilutive securities
|
||||||||||||||||||||||||
Convertible
debt
|
— | — | 112,500 | 2,500,000 | ||||||||||||||||||||
Warrants
|
— | — | — | 1,766,546 | ||||||||||||||||||||
Options
and stock grants
|
— | — | — | 600,979 | ||||||||||||||||||||
Diluted (Loss) Income Per
Share:
|
||||||||||||||||||||||||
Net
(Loss) Income
|
$ | (2,773,737 | ) | 11,311,574 | $ | (0.25 | ) | $ | 1,066,837 | 15,691,982 | $ | 0.07 |
6
Stock-Based
Compensation
The
Company accounts for stock-based compensation pursuant to FASB ASC Topic 505,
“Share-Based Payment,” which requires compensation costs related to share-based
transactions, including employee stock options, to be recognized in the
financial statements based on fair value.
Stock-based
compensation cost is estimated based on the fair value of the award at the grant
date using the Black-Scholes option pricing model. The fair value of
restricted stock units granted is based on the closing market price of the
Company’s common stock on the date of the grant. The fair value of
these awards, adjusted for estimated forfeitures, is amortized over the
requisite service period of the award, which is generally the vesting
period.
New
Accounting Guidance
In
October 2009, the Financial Accounting Standards Board (“FASB”) issued
accounting guidance that changes the accounting model for revenue arrangements
that include both tangible products and software elements that function together
to deliver the product’s essential functionality. The accounting
guidance more closely reflects the underlying economics of these
transactions. We are evaluating the impact of adopting this guidance
which is effective for us on January 1, 2011.
In
October 2009, the FASB issued accounting guidance that sets forth the
requirements that must be met for a company to recognize revenue from the sale
of a delivered item that is part of a multiple-element arrangement when other
items have not yet been delivered. The new guidance will be effective for the
Company prospectively for revenue arrangements entered into or materially
modified on or after January 1, 2011. Early adoption of this standard
is permitted. The Company is still assessing the potential impact of
adopting this new guidance.
In August
2009, the FASB issued accounting guidance which provides clarification that, in
the absence of a quoted price for a liability, companies may apply methods that
use the quoted price of an investment traded as an asset or other valuation
techniques consistent with the fair-value measurement principle. The
Company does not expect this accounting guidance, which is effective for us
beginning October 1, 2009, to have a material impact on our consolidated
financial position, results of operations or cash flows.
In June
2009, the FASB issued accounting guidance which requires entities to provide
greater transparency about transfers of financial assets and a company’s
continuing involvement in those transferred financial assets. The
accounting guidance also removes the concept of a qualifying special-purpose
entity. The guidance is effective for us beginning January 1, 2010
and we do not expect its adoption to have a material impact on our consolidated
financial position, results of operations or cash flows.
Recently
Adopted Accounting Standards
In June
2009, the FASB issued authoritative guidance to establish the FASB Accounting
Standards Codification (the “Codification”) as the source of authoritative
accounting principles and the framework for selecting the principles used in the
preparation of financial statements of non-governmental entities that are
presented in conformity with generally accepted accounting principles in the
United States. The Codification, which changes the referencing of
financial standards, supersedes current authoritative guidance and is effective
for interim or annual financial periods ending after September 15, 2009.
The Codification is not intended to change or alter existing GAAP and it is not
expected to result in a change in accounting practice for the Company. The
Company has updated its references to reflect the Codification.
7
In May
2009, the FASB issued accounting guidance which establishes general standards of
accounting for, and disclosures of, subsequent events that occurred after the
balance sheet date but prior to the issuance of financial statements. In
addition, the new guidance requires disclosure of the date through which an
entity has evaluated subsequent events and whether this date represents the date
the financial statements were issued or were available to be issued. The
adoption of this accounting guidance as of June 30, 2009 did not have a material
impact on the consolidated financial position, results of operations or cash
flows of the Company.
In April
2009, the FASB issued additional accounting guidance for other-than-temporary
impairments to improve the consistency in the timing of impairment recognition,
as well as provide greater clarity to investors about credit and non-credit
components of impaired debt securities that are not expected to be
sold. The adoption of this accounting guidance did not have a
material impact on our consolidated financial position, results of operations or
cash flows.
In April
2009, the FASB issued accounting guidance which primarily addresses the
measurement of fair value of financial assets and liabilities when there is no
active market or where the price inputs being used could be indicative of
distressed sales. The adoption of this accounting guidance did not
have a material impact on our consolidated financial position, results of
operations or cash flows.
NOTE
2- EQUITY COMPENSATION PROGRAM AND STOCK BASED COMPENSATION
a)
|
2000
Equity Compensation Program
|
The
Company’s 2000 Equity Compensation Program provides for grants of options, stock
appreciation rights and performance shares to employees, officers, directors and
others who render services to the Company. The program consists of
the following four plans: (i) the Incentive Equity Compensation Program, which
provides for grants of “Incentive Stock Options”, (ii) the Supplemental Program,
which allows the granting of stock appreciation rights and (iv) the Performance
Share Program under which eligible participants may receive stock awards,
including restricted stock and restricted stock units. The plans are
administered by the Compensation Committee of the Board of
Directors. Under these plans, an aggregate of up to 6,000,000 shares
of common stock may be granted. The 2000 Equity Compensation plan
expires in August 2010.
b)
|
Stock
Option Expense
|
The
Company's results for the three months ended September 30, 2009 and 2008 include
stock-based compensation expense for stock option grants totaling $14,905 and
$8,733, respectively. Such amounts have been included in the
accompanying Consolidated Statements of Operations within cost of goods sold in
the amount of $2,162 ($2,076 for 2008), and selling, general and administrative
expenses in the amount of $12,743 ($6,657 for 2008).
The
Company’s results for the nine months ended September 30, 2009 and 2008 include
stock-based compensation expense for stock option grants totaling $50,275 and
$26,200, respectively. Such amounts have been included in the
accompanying Condensed Consolidated Statements of Operations within cost of
goods sold in the amount of $6,098 ($6,229 for 2008), and selling, general and
administrative expenses in the amount of $44,177 ($19,971 for
2008).
As of
September 30, 2009, there was $118,658 of unrecognized compensation costs, net
of estimated forfeitures, related to non-vested stock options, which are
expected to be recognized over a weighted average period of approximately 2.75
years.
8
The fair
value of option grants used to determine the stock option expense is estimated
using the Black-Scholes option pricing model, as of the date of the
grant. The Company follows guidance under FASB ASC Topic 505,
“Share-Based Payment,” when reviewing and updating its
assumptions. Expected volatility is based upon the historical
volatility of the Company’s stock and other contributing factors. The
risk-free interest rate is based on the U.S. Treasury yield curve in effect at
the time of the grant.
The
following range of weighted-average assumptions were used to determine the fair
value of stock option grants during the nine months ended September 30, 2009 and
2008, respectively:
Nine
Months Ended
September
30,
|
||||||||
2009
|
2008
|
|||||||
Expected
Dividend yield
|
0.00 | % | — | |||||
Expected
Volatility
|
180-218 | % | — | |||||
Risk-free
interest rate
|
2.5–3.2 | % | — | |||||
Expected
term
|
8
-10 years
|
— |
The
Company did not grant any stock options during the nine months ended September
30, 2008.
c)
|
Stock
Option Activity
|
For the
nine months ended September 30, 2009, there were 97,584 options granted with a
weighted average estimated fair value of $1.68 and a weighted average exercise
price of $1.70, which was equal to the closing market price on the date of the
grant. Of these grants, 7,742 stock options had a term of 3 years and
vested as of the grant date.
The
following table represents stock options granted, exercised, and forfeited
during the nine month period ended September 30, 2009:
Weighted
|
||||||||||||||||
Weighted
|
Average
|
|||||||||||||||
Average
|
Remaining
|
|||||||||||||||
Exercise
|
Contractual
|
Aggregate
|
||||||||||||||
Number
of
|
Price
per
|
Term
|
Intrinsic
|
|||||||||||||
Stock
Options
|
Options
|
Option
|
(years)
|
Value
|
||||||||||||
Outstanding
at January 1, 2009
|
1,030,139 | $ | 1.50 | 3.9 | $ | 161,000 | ||||||||||
Granted
|
97,584 | 1.70 | ||||||||||||||
Exercised
|
(59,500 | ) | 1.27 | |||||||||||||
Expired
|
(25,000 | ) | 1.00 | |||||||||||||
Outstanding
at September
30, 2009
|
1,043,223 | $ | 1.54 | 3.15 | $ | — | ||||||||||
Exercisable
at September
30, 2009
|
949,995 | $ | 1.53 | 2.75 | $ | — |
9
The
following table represents non-vested stock options granted, vested and
forfeited for the nine months ended September 30, 2009.
Non-vested
Options
|
Options
|
Weighted-Average
Grant-Date
Fair
Value
|
||||||
Non-vested -
January 1, 2009
|
33,220 | $ | 1.48 | |||||
Granted
|
97,584 | $ | 1.68 | |||||
Vested
|
(37,576 | ) | $ | 1.31 | ||||
Expired
|
— | — | ||||||
Non-vested
– September 30, 2009
|
93,228 | $ | 1.67 |
The total
fair value of options vested during the nine months ended September 30, 2009 and
2008 was $49,000 and $35,000, respectively.
d)
|
Restricted
Stock Unit Awards
|
There
were no grants of restricted stock units under this plan during the nine months
ended September 30, 2009.
During
the three and nine months ended September 30, 2008, the Company granted 6,000
and 23,500 restricted stock unit awards, respectively, with a fair value of
$15,300 and $85,300 based on the closing market price of the Company’s common
stock, on the grant date. Restricted stock unit awards generally vest
over a three year period contingent on continued employment or service over the
vesting period.
The
Company's results for the three and nine months ended September 30, 2009 include
stock-based compensation expense of $8,938 and $36,158, respectively, for
restricted stock unit grants under the Company’s 2000 Performance Share
Program. Such amounts have been included in the accompanying
Condensed Consolidated Statements of Operations within cost of goods sold in the
amount of $1,333 and $4,002, respectively, and in selling, general and
administrative expenses in the amount of $7,605 and $32,156,
respectively. The Company's results for the three and nine months
ended September 30, 2008 include stock-based compensation expense of $10,690 and
$30,370, respectively, for restricted stock unit grants under the Company’s 2000
Performance Share Program. Such amounts have been included in the
accompanying Condensed Consolidated Statements of Operations within cost of
goods sold in the amount of $2,185 and $4,855, respectively, and in selling,
general and administrative expenses in the amount of $8,505 and $25,515,
respectively.
A summary
of the Company’s non-vested restricted stock units at September 30, 2009 is
presented below:
10
Restricted
Stock Units
|
Weighted-Average
Grant-Date Fair Value
|
|||||||
Non-vested
- January 1, 2009
|
31,500 | $ | 3.72 | |||||
Granted
|
— | — | ||||||
Vested
|
9,504 | $ | 3.69 | |||||
Forfeited
|
— | — | ||||||
Non-vested
– September 30, 2009
|
21,996 | $ | 3.74 |
NOTE
3- WORK-FORCE REDUCTION
In the
first quarter of 2009, the Company reduced its combined work-force by
approximately 23%, in order to eliminate costs and align PPGI’s workforce with
its current business requirements while ensuring the Company would continue to
meet its customers’ needs. The reductions affected both the Company’s
Northvale, NJ and the Sarasota, FL operations. Annualized savings from the
reductions are expected to be approximately $1.1 million. Severance
payments expensed in the first quarter of the year but paid in the first and
second quarters of the year totaled approximately $140,000.
NOTE
4- EXPIRATION OF WARRANTS
On July
13, 2009, 893,790 outstanding warrants, with an estimated fair value of $1.29
each, expired in accordance with the terms of the warrant
agreement. These warrants provided the right to the holder to
purchase an equivalent number of shares of the Company’s common stock at an
exercise price of $1.35 per share. The Company has a balance of 1,935,000
outstanding warrants exercisable at $1.35 per share with various expiration
dates through April 1, 2014.
NOTE
5- GOODWILL IMPAIRMENT
Goodwill
represents the excess of purchase price and related costs over the fair value
assigned to the net tangible and identifiable assets of business
acquisitions. The Company tests goodwill for impairment on an annual
basis in December of each year, or more frequently whenever events occur or
circumstances exist that indicates that impairment may exist. During the third
quarter of 2009, the Company experienced further declines in sales and
profitability, and economic and industry conditions remained weak. As a result,
the Company determined that testing for impairment of goodwill was required for
its two reporting units which the Company has identified as its two geographical
operating units in Florida and New Jersey. In making this assessment, management
considered a number of factors which include, among others, historical and
current operating results and cash flows, current projections of future
financial results and cash flows, business plans, current and projected economic
conditions and industry trends. There are inherent uncertainties
associated with these factors and significant judgment is involved in evaluating
each.
The
testing for goodwill impairment is a two-step process. The first step
is to compare the fair value of each reporting unit to its carrying
value. If the fair value of the reporting unit exceeds its carrying
amount, goodwill is not considered to be impaired as of the measurement date.
Otherwise, if the carrying value exceeds the fair value, a second step must be
followed to determine the level of impairment. In establishing the
fair value of the reporting unit, the Company uses both a market based approach
and an income based approach as part of its valuation
methodology. Since quoted market prices in an active market are not
separately available for the Company’s reporting units, the market based method
estimates the fair value of the reporting unit utilizing an industry multiple of
projected earnings before interest taxes and depreciation
(“EBITDA”). Due to the small capitalization value of the Company, the
low trading volume of its stock and the niche market served by its products, the
application of available industry comparables in establishing fair value
requires a high degree of management judgment, and the actual fair value that
could be realized could differ from those used to evaluate the impairment of
goodwill. The income approach determines fair value based on the estimated
discounted cash flows that each reporting unit is expected to generate in the
future. For each method, the sensitivity of key assumptions are tested by using
a range of estimates and the results of each method are corroborated as part of
management’s determination of fair value.
11
The
second step of the testing process involves calculating the fair value of the
individual assets and liabilities of the reporting unit and measuring the
implied fair value of the goodwill against its carrying value to determine
whether an adjustment to the carrying value of goodwill is required. This
process also has inherent risks and uncertainties and requires significant
management judgment.
Upon
completion of the first step, the Company concluded that the carrying value of
its Florida reporting unit exceeded its fair value and a step two analysis was
required. The step-two analysis resulted in the Company recording an
impairment charge against the full carrying value of goodwill of its Florida
reporting unit, in the amount of $1,558,000. The Company has determined that the
carrying value of its goodwill incurred in connection with its acquisitions of
its New Jersey reporting unit in the amount of $312,000 is not impaired as of
September 30, 2009.
The
changes in the carrying amount of goodwill during the nine months ended
September 30, 2009 were as follows:
Amount
(in thousands) |
|||||
Balance
at December 31, 2008
|
$ | 1,870 | |||
Impairment
of Goodwill
|
(1,558 | ) | |||
Balance
at September 30, 2009
|
`
|
$ | 312 |
Prior to
its assessment of goodwill for impairment, the Company evaluated its property
and equipment and intangible assets for impairment. Based on the
results of the tests performed, management concluded that that an impairment of
its long-lived assets did not exist at September 30, 2009.
12
ITEM
2. MANAGEMENT'S DISCUSSION AND
ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF
OPERATIONS
Caution
Regarding Forward Looking Statements
This
Quarterly Report contains forward-looking statements as that term is defined in
the federal securities laws. The Company wishes to insure that any
forward-looking statements are accompanied by meaningful cautionary statements
in order to comply with the terms of the safe harbor provided by the Private
Securities Litigation Reform Act of 1995. The events described in the
forward-looking statements contained in this Annual Report may not
occur. Generally, these statements relate to business plans or
strategies, projected or anticipated benefits or other consequences of the
Company’s plans or strategies, projected or anticipated benefits of acquisitions
made by the Company, projections involving anticipated revenues, earnings, or
other aspects of the Company’s operating results. The words “may”,
“will”, “expect”, “believe”, “anticipate”, “project”, “plan”, “intend”,
“estimate”, and “continue”, and their opposites and similar expressions are
intended to identify forward-looking statements. The Company cautions
you that these statements are not guarantees of future performance or events and
are subject to a number of uncertainties, risks, and other influences, many of
which are beyond the Company’s control, that may influence the accuracy of the
statements and the projections upon which the statements are
based. Factors which may affect the Company’s results include, but
are not limited to, the risks and uncertainties discussed in Items 7 and 7A of
the Company’s most recent Annual Report on Form 10-K for the year ended December
31, 2008, as filed with the Securities and Exchange Commission on March 31,
2009. Any one or more of these uncertainties, risks, and other
influences could materially affect the Company’s results of operations and
whether forward-looking statements made by the Company ultimately prove to be
accurate. Readers are further cautioned that the Company’s financial
results can vary from quarter to quarter, and the financial results for any
period may not necessarily be indicative of future results. The
foregoing is not intended to be an exhaustive list of all factors that could
cause actual results to differ materially from those expressed in
forward-looking statements made by the Company. The Company’s actual
results, performance and achievements could differ materially from those
expressed or implied in these forward-looking statements. The Company
undertakes no obligation to publicly update or revise any forward looking
statements, whether from new information, future events, or
otherwise.
Critical
Accounting Policies and Estimates
Our
significant accounting policies are described in Note 1 of the accompanying
consolidated financial statements and further discussed in our annual financial
statements included in our annual report on Form 10-K for the year ended
December 31, 2008. In preparing our condensed consolidated financial
statements, we made estimates and judgments that affect the results of our
operations and the value of assets and liabilities we report. These
include estimates used in evaluating goodwill and intangibles for impairment
such as market multiples used in determining the fair value of reporting units,
discount rates applicable in determining net present values of future cash
flows, projections of future sales, earnings and cash flow and capital
expenditures. It also includes estimates about the amount and timing
of future taxable income in determining the Company’s valuation allowance for
deferred income tax assets. Our actual results may differ from these
estimates under different assumptions or conditions.
13
For
additional information regarding our critical accounting policies and estimates,
see the section entitled “Management’s Discussion and Analysis of Financial
Condition and Results of Operations” in our annual report filed with the
Securities and Exchange Commission on Form 10-K for the year ended December 31,
2008.
Results
of Operations
Photonic
Products Group, Inc.’s business falls into two general product categories:
Optical Components (including standard and custom optical components and
assemblies, crystals and crystal components), and Laser Accessories (including
wavelength conversion instruments that employ nonlinear or electro-optical
crystals to perform the function of wavelength conversion, or optical switching,
and optical Q-switches). Its optical components product lines and
services are brought to market through three business units: INRAD, Laser Optics
and MRC Optics (“MRC”). Laser accessories are manufactured and sold
by INRAD. The Company operates manufacturing facilities in Florida
and New Jersey.
Revenue
Sales for
the three months ended September 30, 2009 were $2,665,000 compared with
$3,803,000 in the third quarter of 2008, down 29.9%. Sales for the
nine months ended September 30, 2009 were $8,100,000 compared with $11,975,000
for the nine months ended September 30, 2008, down $3,875,000 or
32.4%.
Sales of
custom optical components in the third quarter and year-to-date declined by
approximately 29.1% and 30.8% compared to the related periods in 2008,
reflecting lower sales activity of this product segment across all three
business units.
Sales of
laser accessories fell by 30.5% in the third quarter this year compared to the
same period last year, as demand for laser systems and related components
remained weak. For the nine months ended September 30, 2009 sales of
laser accessories were 42.5% lower than 2008.
The
decrease in the Company’s sales reflects lower than anticipated levels of new
customer orders resulting from reduced customer demand for our products amid the
lingering effects of the economic recession. In particular, the
effect has most significantly impacted sales to the Company’s larger OEM
customers in both the defense and commercial sector.
Sales to
major customers, defined as those who represent more than 10% of period sales,
remained at the same overall percentage of total sales representing 72.4% and
73.2% of sales in the nine months ended September 30, 2009 and 2008,
respectively. However sales to these top ten customers declined, in
dollar terms, by almost 32.5%. Sales to two major OEM customers in the defense
sector fell by 52.5% and 82.8%, respectively, for the nine month period ended
September 30, 2009, from the same period in the previous year. Sales to the
Company’s top five customers declined by approximately $2.4 million or 35.2%,
from the nine month period ended September 30, 2008.
Despite
the shortfall in sales, the Company’s sales and marketing efforts continue to
focus on the development of new markets and products, expanding current markets
and adding new customers to its existing base to position itself to take
advantage of future opportunities as they arise.
Product
backlog was $4.3 million at September 30, 2009 compared to backlog of $8.7
million at September 30, 2008. The current period backlog level
reflects lower new order activity through the first three quarters of
2009. The Company had a book to bill ratio of 0.58 to 1 in the third
quarter and a book to bill ratio of 0.78 to 1 for the nine months ended
September 30, 2009.
Cost
of Goods Sold
For the
three months ended September 30, 2009, cost of goods sold was $2,058,000 or
77.2% of sales compared to $2,738,000 or 72.0% of sales, for the same period
last year. For the nine months ended September 30, 2009, cost of
goods sold was $6,693,000 or 82.6% of sales compared to $8,188,000 or 68.4% for
the nine months ended September 30, 2008.
14
Material
costs in dollar terms were down by 31.3% and 26.9% in the third quarter and nine
month period in 2009 compared to the same periods in 2008, primarily as a result
of lower sales volumes this year. As a percentage of sales, however,
material costs were unchanged in the third quarter and higher for the nine
months ending September 30, 2009, compared to 2008. Material costs at
MRC rose as a result of a sales mix of products with higher metal cost
components. This offset reductions in material costs in the INRAD
business unit which were driven by lower sales of laser accessories and systems
which have a high material cost component.
In the
third quarter of 2009, manufacturing wages and salaries, net of termination
costs, fell by 19.3%, year over year, as the impact of the Company’s work force
reduction initiated in the first quarter of 2009, began to fully impact
costs. For the nine months ended September 30, 2009, manufacturing
and wages were down 12.9% compared to the same period in
2008. Despite the savings, overall labor costs as a percentage of
sales, increased as sales declines outstripped wage and salary reductions after
accounting for related termination costs.
For the
three months ended September 30, 2009, manufacturing overhead decreased by
$215,000 or 28.2% from the third quarter in 2008 and $369,000 or 16.9% lower for
the comparable nine month periods in 2009 and 2008. Lower costs
reflect management’s continued tight control of expenditures and cost-reduction
plans in response to lower sales and production levels.
Despite
management’s cost reduction efforts, manufacturing overhead as a percentage of
sales for the three months ended September 30, 2009 remained the same as the
comparable period in 2008. For the nine months ended September 30,
2009, manufacturing overhead increased as a percentage of sales compared to the
prior year, as the decline in sales and gross margin dollars outpaced the
decrease in costs. This result also reflects the large percentage of
fixed or semi-fixed costs which are relatively unaffected by changes in the
Company’s sales volume.
Gross
margin in the third quarter was $607,000 or 22.8%, compared with $1,065,000 or
28.0% in the comparable period of 2008, reflecting the factors discussed
above. For the nine months ended September 30, 2009, the gross margin
was $1,409,000 or 17.4%, compared with $3,786,000 or 31.6% for the nine months
ended September 30, 2008.
Selling,
General and Administrative Expenses
Selling,
general and administrative expenses (“SG&A” expenses) in the three months
ended September 30, 2009 were $747,000 or 28.0% of sales compared to $949,000 or
25.0% of sales for the three months ended September 30, 2008. This
represents a decrease of approximately $203,000 or 21.3%. SG&A
salaries and wages and fringe benefits expense were down $140,000 reflecting
personnel reductions implemented in the first quarter of 2009.
For the
nine months ended September 30, 2009 SG&A expenses were $2,533,000 or 31.3%
of sales compared to $2,914,000 or 24.3% for the nine months ended September 30,
2008, a decrease of $380,000 or 13.1%. SG&A salaries and wages
and fringe benefits expense were down by approximately $220,000 in comparison to
last year’s levels, as discussed above. In addition, professional
fees related to recruiting and relocation fees and Sarbanes-Oxley support were
down by a total of $57,000 for the nine months ended September 30, 2009,
compared to last year. The Company plans to continue its focus on
tight cost control and closely monitor and manage discretionary SG&A
expenses to identify opportunities for future cost reductions.
15
Operating
(Loss) Income
The
Company had an operating loss of $1,698,000 in the three months ended September
30, 2009 and an operating loss of $2,684,000 in the nine months ended September
30, 2009 after recording a non-cash charge for the impairment of goodwill of
$1,558,000, as discussed in Note 5 of our Financial Statements,
above. Excluding the charge for goodwill impairment, the Company had
an operating loss of $140,000 and $1,126,000 for the three and nine months ended
September 30, 2009, primarily reflecting the significant decrease in sales, as
discussed above. This compares to operating income of $116,000 and
$872,000 for the three and nine months ended September 30, 2008,
respectively.
Other
Income and Expense
For the
three months ended September 30, 2009, net interest expense was $32,000, a
slight decrease from $33,000 in the third quarter of last year.
For the
nine months ended September 30, 2009, net interest expense was $97,000, a
decrease from $143,000 in the comparable period last year. The lower
net interest expense for the third quarter and year-to-date periods resulted
from the Company’s reduced balances of fixed interest debt reflecting the
Company’s re-payment of a $1.7 million Secured Promissory Note in the first
quarter of 2008. In addition, interest payments were lower on reduced
balances of other notes and capital leases. The overall decline in
interest expense was offset by a decrease in interest income in both the three
and nine months ended September 30, 2009, which is netted against interest
expense. The decrease was the result of interest rates reductions
which impacted returns on the Company’s cash balance.
Interest
expense for the nine months ended September 30, 2008, included the amortization
of warrant costs in the amount of $37,000 related to the $1.7 million note which
was retired in the first quarter of 2008, as discussed above.
In the
first quarter of 2009, the Company sold surplus tools and recorded a gain of
$7,371 on the sale.
Income
Taxes
The
Company uses the asset and liability method of accounting for income
tax. This method recognizes deferred tax liabilities and assets for
the expected future tax consequences of events that have been recognized in the
Company’s financial statements or tax returns. Deferred tax
liabilities and assets are determined based on the difference between the
financial statements carrying amounts and the tax basis of assets and
liabilities using enacted tax rates in effect in the years in which the
differences are expected to reverse. Valuation allowances are provided against
deferred tax assets, including net operating losses, if it is anticipated that
it is more likely than not that they will not be realized through future taxable
earnings or implementation of tax planning strategies. In making this
assessment, significant weight is given to evidence that can be objectively
verified, such as recent historic taxable income levels as well as current tax
rates in effect in the jurisdictions in which the Company
operates. The Company must also make assumptions about future
earnings, tax rates and tax laws expected for in the future.
The
Company recorded a tax benefit of $392,000 related to the recognition of
deferred tax assets for net operating losses incurred during the first six
months of 2009. In the third quarter, due to the negative impact of
the economic recession on the Company’s profitability, we reevaluated the
likelihood that the benefit of deferred tax assets would be realized in future
periods. As a result, we increased our estimate of the valuation
allowance, in the third quarter, to a level that, in management’s judgment,
would meet the more likely than not threshold, and we recorded a valuation
allowance against our deferred tax assets and a corresponding deferred tax
provision in the amount of $392,000. This offset the benefit recorded in the
first six months of the year.
16
In
evaluating the Company’s ability to recover deferred tax assets in future
periods, management considered the available positive and negative factors,
including the Company’s past operating results, the existence of cumulative
losses and near term forecasts of future taxable income that is consistent with
the plans and estimates management is using to manage the underlying business
and concluded that it was more likely than not that the tax benefits would not
be fully recoverable in future periods. As of September 30, 2009, the
Company has recognized $408,000 of its deferred tax asset, net of a valuation
allowance of $2,441,000 which it estimates will be recoverable in future
periods.
The
Company recognizes a tax benefit from an uncertain tax position only if it is
more likely than not to be sustained before being recognized in the financial
statements. The tax benefits recognized in the financial statements
from such positions are measured based on the largest benefit that has a more
likely than not chance of being realized upon ultimate
resolution. The Company recognizes potential interest and penalties
related to income tax positions as a component of the provision for income taxes
on the consolidated statements of income in any futures periods in which the
Company must record a liability. Since the Company has not recorded a liability
related to uncertain tax positions at September 30, 2009, there was no
impact on the Company’s effective tax rate.
Net
(Loss) Income
The
Company had a net loss of $2,122,000 and $2,774,000, respectively, for the three
and nine months ended September 30, 2009 as compared to net income of $169,000
and $954,000, for the three and nine months ended September 30, 2008, primarily
attributable to the $1,558,000 non-cash charge for goodwill impairment, as well
as lower sales volumes and reduced profit margins, net of the positive impact of
manufacturing cost and SG&A cost reductions in the current periods, as
discussed above.
Liquidity
and Capital Resources
The
Company’s primary source of cash has been from operating cash
flows. Other sources of cash include proceeds received from the
exercise of stock options and warrants in return for the issuance of common
stock. The Company’s major uses of cash in the past two years have
been for repayment and servicing of outstanding debt and for capital
expenditures. Based upon the current level of operations we believe
our existing cash resources, as well as cash flows from future operating
activities, will be adequate to meet our anticipated cash requirements for
principal and interest payments on our outstanding indebtedness, working
capital, new product development, capital expenditures, contractual obligations
and other operating needs over the balance of the year. Consistent
with historical results, during the first nine months of 2009 and 2008, our
primary sources of capital were cash from operating activities.
17
The
following table summarizes the net cash provided and used by operating,
investing and financing activities for the nine months ended September 30, 2009
and 2008:
Nine
months ended September 30,
|
||||||||
2009
|
2008
|
|||||||
(in
thousands)
|
||||||||
Net
cash provided by operating activities
|
$
|
451
|
$
|
879
|
||||
Net
cash provided by (used in) investing activities
|
624
|
(716)
|
||||||
Net
cash used in financing activities
|
7
|
(693)
|
||||||
Net
increase (decrease) in cash and cash equivalents
|
$
|
1,082
|
$
|
(530)
|
Net cash
flow provided by operating activities was $451,000 for the nine months ended
September 30, 2009, compared with net cash flow provided by operating activities
of $879,000 in the same period last year. The decrease in operating
cash flows was due to several factors, but primarily resulted from the Company’s
net loss of $1,126,000 before the non-cash charge for goodwill impairment
compared to net income of $872,000 in the comparable period last
year. This decrease was offset by improved working capital levels
related to reductions in inventory and account receivable levels, net of lower
customer advances, as compared to the nine month ended September 30,
2008.
In the
first nine months of 2009, reductions in accounts receivable provided $1,094,000
of cash flow. Accounts receivable balances fell from $2,811,000 at
December 31, 2008 to $1,717,000 at September 30, 2009 compared to a decrease in
accounts receivable in the amount of $233,000 in the comparable period in
2008.
Inventory
levels decreased by $292,000 to $2,440,000 at September 30, 2009 compared to an
increase of $296,000 in the nine month period ended September 30,
2008. The decrease in inventory this year is primarily attributable
to a decline in booking levels and lower production activity due to reduced
customer demand in the first nine months of 2009. In the first
quarter of 2008 delayed shipments at MRC led to an increase in inventory levels
in that period.
Customer
advances decreased by $341,000 to $116,000 in the first nine months of 2009,
directly a result of lower booking levels in the first nine months of
2009. Customer advances vary with the timing of orders from
customers. In the comparable period in 2008, customer advances
increased by $12,000 to $882,000.
Cash
flows provided by investing activities were $624,000 in the first nine months of
2009, as the Company redeemed $800,000 of certificates of deposit with original
terms greater than 90 days terms, upon maturity. Under U.S. GAAP,
these were required to be classified separately from cash and cash equivalents
at December 31, 2008.
Capital
expenditures for the nine months ended September 30, 2009 were $139,000 down
from $726,000, last year. Management has instituted a review program
for planned capital expenditures in order to identify and defer expenditures,
where practical, to minimize the impact on the Company’s cash flows over the
balance of the year.
Net cash
provided by financing activities during the first nine months of 2009 totaled
$7,000 and consisted primarily of principal payments of $134,000 on other long
term notes offset by the proceeds from the exercise of warrants of $67,000 and
on the exercise of stock options in the amount of $75,000. In the
first nine months of 2008, net cash used in financing activities was
$692,000. During that period, the Company repaid a secured promissory
note for $1,700,000 (plus accrued interest of $477,000) to Clarex Limited, a
major shareholder. This was offset by proceeds received from the
exercise of warrants and stock options during the first nine months of 2008, in
the amount of $808,000 and $258,000, respectively.
18
The
Company had a net increase in cash and cash equivalents of $1,082,000 in the
nine months ended September 30, 2009. In the corresponding period,
last year the Company had a net decrease of cash and cash equivalents of
$530,000.
Cash and
cash equivalents at September 30, 2009 were $3,754,000. At December
31, 2008, the Company had $3,472,000 in cash and cash equivalents including
certificates of deposit with original maturities greater than 90
days.
In March
2009, the maturity dates of two 6% Subordinated Convertible Promissory Notes to
related parties, totaling $2,500,000, were extended to April 1, 2011, at the
same terms. The Notes are convertible into 2,500,000 Units consisting
of 2,500,000 shares of common stock and warrants to acquire 1,875,000 shares of
common stock at a price of $1.35 per share. The expiration date of
the warrants has been extended to April 1, 2014.
On July
13, 2009, 894,000 outstanding warrants, each with a fair market value of $1.29,
expired in accordance with the terms of the warrant agreement. These
warrants were originally issued in 2004 when the Company entered into an
agreement with an investment banking firm to raise equity through a private
placement of the Company’s common stock.
ITEM
3. QUANTITATIVE AND QUALITATIVE
DISCLOSURES ABOUT MARKET RISK
The
Company believes that it has limited exposure to changes in interest rates from
investments in certain money market accounts. The Company does not
utilize derivative instruments or other market risk sensitive instruments to
manage exposure to interest rate changes.
ITEM
4. CONTROLS AND
PROCEDURES
a.
Disclosure
Controls and Procedures
During
the three months ended September 30, 2009, our management, including the
principal executive officer and principal financial officer evaluated our
disclosure controls and procedures (as defined in Rules 13a-15(e) and 15d-15(e)
under the Securities and Exchange Act of 1934) related to the recording,
processing, summarization and reporting of information in the reports that we
file with the SEC. These disclosure controls and procedures have been
designed to ensure that material information relating to us, including our
subsidiaries, is made known to our management, including these officers and that
this information is recorded, processed, summarized, evaluated and reported, as
applicable, within the time periods specified in the SEC’s rules and
forms. Due to inherent limitations of control systems, not all
misstatements may be detected. Our controls and procedures can only
provide reasonable, not absolute, assurance that the above objectives have been
met.
Based
upon their evaluation, our principal executive officer and principal financial
officer concluded that our disclosure controls and procedures were effective as
of September 30, 2009 to reasonably ensure that information required to be
disclosed by us in the reports we file or submit under the Securities Exchange
Act of 1934 is recorded, processed, summarized and reported, within the time
periods specified in the SEC’s rules and forms.
b. Changes
in Internal Controls Over Financial Reporting
There
were no changes in our internal control over financial reporting during the
quarter that have materially affected, or are reasonably likely to materially
affect, our internal control over financial reporting.
19
PART
II. OTHER
INFORMATION
ITEM
1. LEGAL
PROCEEDINGS
None.
ITEM
1A. RISK
FACTORS
Not
applicable
ITEM
2. UNREGISTERED SALES
OF EQUITY SECURITIES AND USE OF PROCEEDS
None.
ITEM
3. DEFAULTS UNDER
SENIOR SECURITIES
None.
ITEM
4. SUBMISSION OF
MATTERS TO A VOTE OF SECURITY HOLDERS
None
ITEM
5. OTHER
INFORMATION
On
September 14, 2009, Dennis G. Romano was appointed to the Company’s Board of
Directors. He will serve under this appointment until the annual
election of directors expected to be in June 2010.
ITEM
6. EXHIBITS
11.
|
An
exhibit showing the computation of per-share earnings is omitted because
the computation can be clearly determined from the material contained in
this Quarterly Report on Form 10-Q.
|
31.1
|
Certificate
of the Registrant’s Chief Executive Officer, Joseph J. Rutherford,
pursuant to Section 302 of the Sarbanes-Oxley Act of
2002.
|
31.2
|
Certificate
of the Registrant’s Chief Financial Officer, William J. Foote, pursuant to
Section 302 of the Sarbanes-Oxley Act of
2002.
|
32.1
|
Certificate
of the Registrant’s Chief Executive Officer, Joseph J. Rutherford,
pursuant to Section 906 of the Sarbanes-Oxley Act of
2002.
|
32.2
|
Certificate
of the Registrant’s Chief Financial Officer, William J. Foote, pursuant to
Section 906 of the Sarbanes-Oxley Act of
2002.
|
20
SIGNATURES
Pursuant
to the requirements of the Securities Exchange Act of 1934, the Registrant has
duly caused this report to be signed on its behalf by the undersigned thereunto
duly authorized.
Photonic
Products Group, Inc.
|
|||
By:
|
/s/ Joseph J. Rutherford | ||
Joseph
J. Rutherford
President
and Chief Executive Officer
|
|||
Photonic
Products Group, Inc.
|
|||
By:
|
/s/ William J. Foote | ||
William
J. Foote
Chief
Financial Officer and Secretary
|
|||
Date: November 16, 2009 |
21